Movement Alert｜BeOne Medicines Falls 3.21% in Regular Trading, Biotech Sector Collective Pullback Compounds Tax Payment Overhang

Market Focus06-30

On June 30, BeOne Medicines (06160.HK) fell 3.21% in regular trading, trading at HKD 168.6/share, with turnover of HKD 311 million.

On the news front, the broader biotechnology sector experienced a collective pullback, creating broad-based selling pressure. Within the sector, AKESO fell 4.8%, Remegen fell 5.65%, TransThera-B fell 6.92%, and 3SBIO fell 2.78%, indicating widespread risk-off sentiment across the biotech space.

The decline also reflects continued digestion of the company's June 26 announcement that a domestic wholly-owned subsidiary was required to pay approximately RMB 446 million in back taxes and late payment surcharges following a notice from local tax authorities. The company stated the matter does not involve administrative penalties and is not a prior-period accounting error. The amount is roughly equivalent to one month of net profit based on Q1 earnings. The stock had fallen 4.37% on A-shares on June 27 and rebounded 3.01% on June 29 before retreating again, suggesting the market continues to weigh the tax impact alongside sector-wide adjustment pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198653526?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 10:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198653526","market":"hk","top_or_hot":-1,"title":"Movement Alert｜BeOne Medicines Falls 3.21% in Regular Trading, Biotech Sector Collective Pullback Compounds Tax Payment Overhang","media":"Market Focus","content":"<p><p>On June 30, BeOne Medicines (06160.HK) fell 3.21% in regular trading, trading at HKD 168.6/share, with turnover of HKD 311 million.</p><p>On the news front, the broader biotechnology sector experienced a collective pullback, creating broad-based selling pressure. Within the sector, AKESO fell 4.8%, Remegen fell 5.65%, TransThera-B fell 6.92%, and 3SBIO fell 2.78%, indicating widespread risk-off sentiment across the biotech space.</p><p>The decline also reflects continued digestion of the company's June 26 announcement that a domestic wholly-owned subsidiary was required to pay approximately RMB 446 million in back taxes and late payment surcharges following a notice from local tax authorities. The company stated the matter does not involve administrative penalties and is not a prior-period accounting error. The amount is roughly equivalent to one month of net profit based on Q1 earnings. The stock had fallen 4.37% on A-shares on June 27 and rebounded 3.01% on June 29 before retreating again, suggesting the market continues to weigh the tax impact alongside sector-wide adjustment pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BeOne Medicines Falls 3.21% in Regular Trading, Biotech Sector Collective Pullback Compounds Tax Payment Overhang</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BeOne Medicines Falls 3.21% in Regular Trading, Biotech Sector Collective Pullback Compounds Tax Payment Overhang\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-30 10:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 30, BeOne Medicines (06160.HK) fell 3.21% in regular trading, trading at HKD 168.6/share, with turnover of HKD 311 million.</p><p>On the news front, the broader biotechnology sector experienced a collective pullback, creating broad-based selling pressure. Within the sector, AKESO fell 4.8%, Remegen fell 5.65%, TransThera-B fell 6.92%, and 3SBIO fell 2.78%, indicating widespread risk-off sentiment across the biotech space.</p><p>The decline also reflects continued digestion of the company's June 26 announcement that a domestic wholly-owned subsidiary was required to pay approximately RMB 446 million in back taxes and late payment surcharges following a notice from local tax authorities. The company stated the matter does not involve administrative penalties and is not a prior-period accounting error. The amount is roughly equivalent to one month of net profit based on Q1 earnings. The stock had fallen 4.37% on A-shares on June 27 and rebounded 3.01% on June 29 before retreating again, suggesting the market continues to weigh the tax impact alongside sector-wide adjustment pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1198653526","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198653526","pubTimestamp":1782787166,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 30, BeOne Medicines (06160.HK) fell 3.21% in regular trading, trading at HKD 168.6/share, with turnover of HKD 311 million.On the news front, the broader biotechnology sector experienced a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"动向提示|BeOne Medicines常规交易跌3.21%生物科技板块集体回调加剧缴税积压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On June 30, BeOne Medicines (06160.HK) fell 3.21% in regular trading, trading at HKD 168.6/share, with turnover of HKD 311 million.On the news front, the broader biotechnology sector experienced a collective pullback, creating broad-based selling pressure. Within the sector, AKESO fell 4.8%, Remegen fell 5.65%, TransThera-B fell 6.92%, and 3SBIO fell 2.78%, indicating widespread risk-off sentiment across the biotech space.The decline also reflects continued digestion of the company's June 26 announcement that a domestic wholly-owned subsidiary was required to pay approximately RMB 446 million in back taxes and late payment surcharges following a notice from local tax authorities. The company stated the matter does not involve administrative penalties and is not a prior-period accounting error. The amount is roughly equivalent to one month of net profit based on Q1 earnings. The stock had fallen 4.37% on A-shares on June 27 and rebounded 3.01% on June 29 before retreating again, suggesting the market continues to weigh the tax impact alongside sector-wide adjustment pressure.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198653526","isCrawlerRequest":true}